Abbott Laboratories & Donald Trump

Abbott Laboratories: Abbott Laboratories, the maker of mifepristone, filed an emergency appeal to the United States — Supreme Court of the United States, which led to the temporary restoration of access to the drug.

Donald Trump: Donald Trump's first-term nominations set the stage for the United States — Supreme Court of the United States that voted to overturn Roe v. Wade. He faces pressure from anti-abortion groups to restrict mifepristone access, while also seeking to steer clear of the issue.

Abbott Laboratories: Abbott Laboratories is a company whose fruit-flavored e-cigarettes were approved by the United States — Food and Drug Administration after Donald Trump reportedly pushed Marty Makary to accelerate the approval process.

Donald Trump: Donald Trump signed off on the plan to fire Marty Makary and publicly acknowledged his departure, citing 'difficulty' Marty Makary was experiencing. Donald Trump's administration will now need to fill another high-level vacancy.

Abbott Laboratories: Abbott Laboratories, a manufacturer of Mifepristone, is a defendant in the lawsuit and has requested a hold on the appeals court's order to seek relief from the United States — Supreme Court of the United States.

Donald Trump: Donald Trump's administration approved a generic version of mifepristone, drawing criticism from anti-abortion advocates who expressed frustration over his inaction to block the pill's distribution.

Abbott Laboratories: Abbott Laboratories, the maker of mifepristone, received temporary relief from Samuel Alito's order, allowing continued mail access to the drug. The company appealed to the United States — Supreme Court of the United States to set aside the appellate court's order and expressed concern about the 'immediate confusion and upheaval' caused by the 5th Circuit's decision.

Donald Trump: The Trump administration has been pressured by antiabortion advocates to reimpose limits on mifepristone, but has sidestepped those demands, pledging only that the United States — Food and Drug Administration would conduct a safety review.